Table 4.
Relationship of treatment success in patients starting antiretroviral therapy after TB treatment in the Kericho District Hospital TB/HIV Clinic (n = 684).
Odds of treatment success (cure or treatment complete) versus death or loss to followup | ||||||
---|---|---|---|---|---|---|
Characteristic | Univariate model | Multivariate model1 | ||||
OR | 95% CI | P | OR | 95% CI | P | |
Age | ||||||
Adult | 0.4 | 0.1–1.5 | 0.2 | — | — | — |
Pediatric | reference | |||||
Gender | ||||||
Male | 0.7 | 0.5–1.1 | 0.09 | — | — | — |
Female | reference | |||||
CD4 Category | ||||||
≥50 cells/mm3 | 2.0 | 1.3–3.1 | <0.01 | 1.7 | 1.0–2.7 | 0.04 |
<50 cells/mm3 | reference | reference | ||||
CD4 Category | ||||||
≥200 cells/mm3 | 3.5 | 1.4–8.9 | <0.01 | 2.4 | 0.9–6.3 | 0.09 |
<200 cells/mm3 | reference | reference | ||||
Time Until ART | ||||||
≥2 weeks | 1.9 | 1.0–3.5 | 0.05 | 1.3 | 0.6–2.7 | 0.5 |
<2 weeks | reference | reference | ||||
Time Until ART | ||||||
≥2 months | 2.0 | 1.3–3.3 | <0.01 | 1.8 | 1.1–3.0 | 0.03 |
<2 months | reference | reference | ||||
Clinic Year | ||||||
Year (2–5, 1 year increment) | 1.2 | 1.0–1.5 | 0.02 | 1.3 | 1.1–1.6 | <0.01 |
previous year | reference | reference |
Notes:
OR: odds ratio, CI: confidence interval.
1Adjusted for CD4 categories, time until ART categories, and clinic year.